ALCHEMAB THERAPEUTICS

Summary

Alchemab Therapeutics is a biotech company developing novel products for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 60 M

Avg. Deal Size£ 60 M

Market Context

Senior Management

Alex Leech
CEO
Olivia Cavlan
Head of Business
Jane Osbourn
CSO